162 related articles for article (PubMed ID: 37495523)
1. Living-Donor Liver Transplantation for Erythropoietic Protoporphyria: A Case Report and Literature Review.
Ogasawara H; Tokodai K; Nakanishi W; Fujio A; Kashiwadate T; Shono Y; Ohta M; Ishikawa Y; Miyagi S; Fujishima F; Unno M; Kamei T
Tohoku J Exp Med; 2023 Oct; 261(2):117-122. PubMed ID: 37495523
[TBL] [Abstract][Full Text] [Related]
2. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Leaf RK; Dickey AK
Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
[TBL] [Abstract][Full Text] [Related]
3. Consecutive Liver and Bone Marrow Transplantation for Erythropoietic Protoporphyria: Case Report and Literature Review.
Portich JP; Ribeiro AS; Rodrigues Taniguchi AN; Backes A; de Souza CFM; Kieling CO; Scherer FF; de Oliveira Poswar F; Leipnitz I; Doederlein Schwartz IV; Sekine L; Rigoni LDC; Marquardt da Silveira L; de Almeida Furlanetto M; Adami MR; Breunig RC; Guedes RR; do Amaral SN; Gonçalves Vieira SM; de Brum Soares T; Silva TO; da Rocha Silla LM; Astigarraga CC; Paz AA; Daudt LE
J Pediatr Hematol Oncol; 2023 Oct; 45(7):416-422. PubMed ID: 37539993
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel.
Lecluse AL; Kuck-Koot VC; van Weelden H; Sigurdsson V; Russel IM; Frank J; Pasmans SG
Eur J Pediatr; 2008 Jun; 167(6):703-6. PubMed ID: 17710435
[TBL] [Abstract][Full Text] [Related]
5. Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study.
Minder AE; Barman-Aksoezen J; Schmid M; Minder EI; Zulewski H; Minder CE; Schneider-Yin X
Ther Adv Rare Dis; 2021; 2():26330040211065453. PubMed ID: 37181106
[TBL] [Abstract][Full Text] [Related]
6. A case of erythrogenic protoporphyria with thyrotoxicosis and liver dysfunction in an adult female.
Li Q; Chen X; Wang H; Tuo B; Zhou Z; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1769-1774. PubMed ID: 38432869
[TBL] [Abstract][Full Text] [Related]
7. Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review.
Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
Biomed Pharmacother; 2023 Feb; 158():114132. PubMed ID: 36525819
[TBL] [Abstract][Full Text] [Related]
8. Effects of iron supplements in individuals with erythropoietic protoporphyria.
Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
Photodiagnosis Photodyn Ther; 2024 Jun; 47():104211. PubMed ID: 38734198
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietic protoporphyria: case reports for clinical and therapeutic hints.
Tumminelli C; Burlo F; Pastore S; Severini GM; Berti I; Marchini S; Zanon D; De Martino E; Tommasini A
Ital J Pediatr; 2023 Nov; 49(1):156. PubMed ID: 37996925
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases.
Najahi-Missaoui W; Dailey HA
Blood; 2005 Aug; 106(3):1098-104. PubMed ID: 15831704
[TBL] [Abstract][Full Text] [Related]
11. Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements.
Raef HS; Rebeiz L; Leaf RK; Hughes O; Jiang P; ElSeht A; Anderson KE; Wheeden K; Kochevar I; Elmariah SB; Dickey AK
JAMA Dermatol; 2023 Feb; 159(2):204-208. PubMed ID: 36630131
[TBL] [Abstract][Full Text] [Related]
12. Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria.
Parker CJ; Desnick RJ; Bissel MD; Bloomer JR; Singal A; Gouya L; Puy H; Anderson KE; Balwani M; Phillips JD
Mol Genet Metab; 2019 Nov; 128(3):309-313. PubMed ID: 31395332
[TBL] [Abstract][Full Text] [Related]
13. Management of erythropoietic protoporphyria with cholestatic liver disease: A case report.
Poli A; Frieri C; Lefebvre T; Delforge J; Mirmiran A; Talbi N; Moulouel B; Six M; Paradis V; Parquet N; Puy H; Schmitt C; Aslangul E; de Fontbrune FS; Gouya L
Mol Genet Metab Rep; 2023 Dec; 37():101018. PubMed ID: 38053924
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protoporphyria.
Levy C; Dickey AK; Wang B; Thapar M; Naik H; Keel SB; Saberi B; Beaven SW; Rudnick SR; Elmariah SB; Erwin AL; Goddu RJ; Hedstrom K; Leaf RK; Kazamel M; Mazepa M; Philpotts LL; Quigley J; Raef H; Ungar J; Anderson KE; Balwani M;
Hepatology; 2024 Mar; 79(3):731-743. PubMed ID: 37505211
[No Abstract] [Full Text] [Related]
15. Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria.
Dickey AK; Naik H; Keel SB; Levy C; Beaven SW; Elmariah SB; Erwin AL; Goddu RJ; Hedstrom K; Leaf RK; Kazamel M; Mazepa M; Philpotts LL; Quigley J; Raef H; Rudnick SR; Saberi B; Thapar M; Ungar J; Wang B; Balwani M;
J Am Acad Dermatol; 2023 Dec; 89(6):1227-1237. PubMed ID: 36041558
[TBL] [Abstract][Full Text] [Related]
16. Liver disease in erythropoietic protoporphyria: insights and implications for management.
Anstey AV; Hift RJ
Postgrad Med J; 2007 Dec; 83(986):739-48. PubMed ID: 18057171
[No Abstract] [Full Text] [Related]
17. Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria.
Madigan KE; Rudnick SR; Agnew MA; Urooj N; Bonkovsky HL
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256864
[TBL] [Abstract][Full Text] [Related]
18. Liver disease in erythropoietic protoporphyria: insights and implications for management.
Anstey AV; Hift RJ
Gut; 2007 Jul; 56(7):1009-18. PubMed ID: 17360790
[No Abstract] [Full Text] [Related]
19. Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria.
Mathias SD; Burke L; Colwell HH; Mensing G; Savage W; Naik H
J Patient Rep Outcomes; 2023 Nov; 7(1):119. PubMed ID: 37982964
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
